6 Tips for Creating Effective Clinical Trial Training
This blog offers practical tips for effective site training to ensure your global clinical trials are compliant and efficient.
Ensuring a Successful and Collaborative SDLC Process
Find out how Advarra's approach to the SDLC lifecycle leads to successful collaborations among sites and sponsors.
4 Questions to Ask CTMS Vendors
Here are four questions to ask during the selection process to offer more insight into your future success with the selected vendor.
IRB Review of Phase I Research: Balancing Ethics and Efficiency
Find out how to address Phase I research challenges to enable efficient IRB review and timely study startup.
3 Must-Haves to Deploy Remote Clinical Trials
Ensure your organization has the tools to both efficiently and compliantly implement remote modalities to best reap the benefits of DCT
Understanding eSource, ePRO, and EDC
eSource, ePRO, and EDC are integral to efficient clinical research. This blog explores how they work together and their differences.
Beginner’s Guide to Minimal Risk Research
How can researchers know when research is minimal risk? Learn an overview and the regulatory flexibilities that might be eligible.
Beginner’s Guide to Independent Asset Reviews
Learn more about independent asset reviews and how they can enhance research operations.
Understanding Medical Science Liaisons and Clinical Liaisons
This blog describes the difference between medical science liaisons and clinical liaisons, and their role in clinical research.
Maintaining a Robust Clinical Trial Pipeline
Explore how the COVID-19 pandemic has changed the clinical trial landscape and how it affects the business pipeline.
4 Key Integrations for Your Clinical Trial Management System
Integrating your clinical trial management system enterprise-wide poses many benefits. Learn how your team can further streamline operations.
Why it is Critical to Have and Enforce a Data Strategy?
Understand a data strategy's role in clinical research and how enforcing one will benefit your studies.